Skip to content

Axiom Space & WFIRM Partner for $15M to Advance Organ Regeneration in Space

This groundbreaking partnership could unlock new possibilities for organ regeneration. The $15 million NSF award supports research in microgravity, with potential benefits for both health and the space industry.

In this picture it looks like a pamphlet of a company with an image of a cup on it.
In this picture it looks like a pamphlet of a company with an image of a cup on it.

Axiom Space & WFIRM Partner for $15M to Advance Organ Regeneration in Space

Axiom Space has partnered with the Wake Forest Institute for Regenerative Medicine (WFIRM) in a pioneering collaboration, supported by a $15 million initial investment from the U.S. National Science Foundation (NSF) Engines award. This alliance aims to advance tissue and organ regeneration research in microgravity, with potential benefits for humanity.

The partnership, dubbed the In-Space Innovation, Translation, and Education Core (ITEC), will focus on several key areas. These include Development and Manufacturing, Biomaterials, Cell Biology, In-Space Manufacturing, and Workforce Development. The ITECs will be user-inspired, tackling technical challenges in tissue and organ regeneration.

Axiom Space, the world's first commercial space station developer, will provide the microgravity environment for these studies. The company's Director of In-Space Manufacturing, Jana Stoudemire, anticipates this collaboration to yield groundbreaking discoveries. Meanwhile, Dr. Anthony Atala, Director of WFIRM, foresees expanded job opportunities and economic development in the Winston-Salem region.

Backed by up to $160 million over a decade, this NSF Engines-funded partnership between Axiom Space and WFIRM seeks to transform tissue and organ regeneration. By exploring these processes in microgravity, the project could unlock new horizons for human health and the global space economy.

Read also:

Latest